Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Sales of Apis and Intermediates	1.14B	-					-	-	-
Finished Drug Sales	220.02M	-					-	-	-
Import and Export Trade	111.39M	-					-	-	-
Raw Materials and Intermediates	-	-					447.50M	434.25M	457.20M
Raw Materials and Intermediates Growth	-	-					3.05%	-5.02%	-
Trading	-	-					127.61M	109.28M	132.89M
Trading Growth	-	-					16.77%	-17.76%	-
Total	1.47B	-					575.11M	543.53M	590.09M
Total Growth	-	-					5.81%	-7.89%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	330.45M	168.05M					-	-	-
China Growth	96.64%	-					-	-	-
Overseas	1.15B	1.09B					-	-	-
Overseas Growth	4.64%	-					-	-	-
Asian Region	-	-					168.71M	154.58M	127.71M
Asian Region Growth	-	-					9.14%	21.04%	-
South America	-	-					133.58M	97.80M	110.39M
South America Growth	-	-					36.58%	-11.40%	-
North America	-	-					30.25M	43.70M	14.11M
North America Growth	-	-					-30.77%	209.73%	-
African Region	-	-					595.50K	733.30K	8.30K
African Region Growth	-	-					-18.79%	8734.94%	-
European Region	-	-					241.97M	246.72M	337.87M
European Region Growth	-	-					-1.92%	-26.98%	-
Total	1.48B	1.26B					575.11M	543.53M	590.09M
Total Growth	16.89%	-					5.81%	-7.89%	-

Source: S&P Global Market Intelligence.